RDNT's Unit DeepHealth Expands AI Breast Suite With FDA-Cleared Tools
RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.
RDNT - RadNet, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$78.00
DETAILS
HIGH:
$91.00
LOW:
$65.00
MEDIAN:
$78.00
CONSENSUS:
$78.00
UPSIDE:
23.20%
Stock News
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite
SOMERVILLE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received FDA 510(k) clearances for two new Breast Suite1 functionalities: Breast Arterial Calcification (BAC) Assessment, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;2 Prior exam integration into ProFound Pro, which enables automatic processing of prior and current studies to track prior lesions and distinguish new lesions, with the goal of improving cancer detection rates and reducing recalls.
RadNet Inc (RDNT) Stock Up 3.8% and Still Undervalued -- GF Score: 79/100
On June 22, 2026, RadNet Inc (RDNT) shares rose 3.8% today, trading at $55.74. The stock has experienced a 52-week range of $50.76 to $85.84, reflecting volatil
Is It Too Late to Buy RadNet Inc (RDNT) After 3.5% Rally? GF Value Says Undervalued
On June 10, 2026, RadNet Inc (RDNT) shares rose 3.5% today, trading at $58.16. The stock has seen a 52-week range between $50.76 and $85.84, indicating signific
RadNet Secures $250 Million Incremental Term Loan to Fund Strategic Growth Opportunities and Reduces the Interest Rates on its Credit Facility by 0.25%
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of outpatient imaging centers and a premier developer of radiology digital health solutions, today announced that it has entered into Incremental Amendment No. 3 (the “Third Amendment”) to its Third Amended and Restated First Lien Credit and Guaranty Agreement, as amended (the “Existing Credit Agreement” and, as amended by the Third Amendment, the “Credit Agreement”).
DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting
SOMERVILLE, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced the launch of Reporting Pro, a next-generation AI-powered solution designed to transform the way radiologists generate clinical reports and findings for their referring physicians.
RadNet Announces a Proposed $200 Million Incremental Term Loan to Fund Strategic Growth Opportunities
LOS ANGELES, June 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of outpatient imaging centers and a premier developer of radiology digital health solutions, today announced that it seeks to secure an incremental term loan in the aggregate principal amount of $200 million (the “Proposed 2026 Incremental Term Loan”) pursuant to a proposed amendment (the “Proposed Amendment”) to its Third Amended and Restated First Lien Credit and Guaranty Agreement, as amended (the “Existing Credit Agreement” and, the transaction, the “Loan Transaction”). If consummated, the Proposed 2026 Incremental Term Loan would be added to and form a part of the existing term loan under the Existing Credit Agreement (the “Existing Term Loan”).
Alpha Wave Global Reduces RadNet Stake, According to Recent SEC Filing
RadNet runs a large outpatient imaging network and is building DeepHealth, its AI radiology platform. The upside is clearer if advanced imaging growth and digital health expansion can develop without pressuring profitability.
Do Options Traders Know Something About RadNet Stock We Don't?
Investors need to pay close attention to RDNT stock based on the movements in the options market lately.
RadNet to Host Men's Health Webinar on June 13, 2026
RadNet hosts free webinar for Men's Health Month, featuring live Q&A and physicians presenting on coronary artery disease, prostate cancer and lung cancer.
RadNet to Host Men's Health Webinar on June 13, 2026
LOS ANGELES, May 28, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of over 440 outpatient imaging centers and a premier developer of radiology digital health solutions, today announced it will host a free webinar for patients and the general public on Saturday, June 13, 2026, in recognition of National Men's Health Month.
Amazon, McDonald Surge Into Jefferies Top Picks Broadcom as Gets Cut
Jefferies refreshed its Franchise Picks list, adding Amazon (AMZN), AppLovin (APP), Credo Technology (CRDO), McDonald's (MCD), RadNet (RDNT), and Thermo Fisher
Jefferies updates its list of highest-conviction Buy-rated stocks
Jefferies, an investment banking and capital management firm, has updated its ‘Franchise Picks' list, which features the company's highest-conviction ‘Buy' rated stocks.
RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript
RadNet, Inc. (RDNT) Q1 2026 Earnings Call Transcript
RadNet Q1 Earnings Call Highlights
RadNet NASDAQ: RDNT reported record first-quarter 2026 revenue and adjusted EBITDA, with management saying demand for advanced imaging and the growing contribution of its Digital Health business helped offset severe winter weather disruptions on the East Coast.
RadNet (RDNT) Reports Strong Revenue Growth Despite EPS Miss in Q1
RadNet (RDNT) has caught the attention of investors following its Q1 earnings report released today. Although the diagnostic imaging company reported a larger-t
RadNet Reports Record First Quarter Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow
LOS ANGELES, May 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 435 outpatient imaging centers and a premier developer of radiology digital health solutions, today reported financial results for its first quarter of 2026.
Will RadNet (RDNT) Report Negative Earnings Next Week? What You Should Know
RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RadNet and Trinity Health's Saint Alphonsus Health System Launch a Multi-Site Joint Venture in Boise, Idaho, to Include a Broad Technology Deployment of DeepHealth Solutions
RadNet forms joint venture with Saint Alphonsus Health System in Idaho, expanding its footprint and deploying DeepHealth OS to transform radiology workflow
RadNet Inc (RDNT) Shares Fall 3.5% -- What GF Score of 84 Tells Investors
On April 29, 2026, RadNet Inc (RDNT) shares fell 3.5% to a current price of $55.89. Over the past week, the stock has declined by 3.4%, and it has decreased by
Price Targets
RadNet price target lowered to $65 from $70 at Barclays
$65.00
(was $53.35)
Andrew Mok
·
Barclays
Jefferies Reiterates Buy Rating on RadNet (RDNT); "We remain bullish on RDNT"
$91.00
(was $72.01)
Brian Tanquilut
·
Jefferies
RadNet initiated with an Overweight at KeyBanc
$92.00
(was $78.38)
UBS
RadNet initiated with an Overweight at KeyBanc
$92.00
(was $78.38)
KeyBanc
Truist Securities Reiterates Buy Rating on RadNet (RDNT)
$90.00
(was $71.22)
David MacDonald
·
Truist Financial
RadNet (RDNT) PT Raised to $95 at Raymond James
$95.00
(was $73.46)
John Ransom
·
Raymond James
RadNet price target raised to $81 from $74 at Truist
$81.00
(was $70.95)
Truist Financial
Truist on RadNet (RDNT): 'Positive EBCD Reimbursement Update From SC'
$74.00
(was $57.28)
David MacDonald
·
Truist Financial
RadNet price target lowered to $88 from $94 at Truist
$88.00
(was $61.77)
David MacDonald
·
Truist Financial
RadNet (RDNT) PT Raised to $100 at Jefferies
$100.00
(was $79.16)
Brian Tanquilut
·
Jefferies
RadNet (RDNT) PT Raised to $94 at Truist Securities
$94.00
(was $83.50)
David MacDonald
·
Truist Financial
RadNet (RDNT) PT Raised to $80 at Truist Securities
$80.00
(was $69.96)
David MacDonald
·
Truist Financial
RadNet price target raised to $80 from $75 at Jefferies
$80.00
(was $67.11)
Brian Tanquilut
·
Jefferies
Barclays Upgrades RadNet (RDNT) to Overweight
$79.00
(was $63.19)
Andrew Mok
·
Barclays
RadNet price target raised to $57 from $51 at Barclays
$57.00
(was $56.89)
Andrew Mok
·
Barclays
RadNet (RDNT) PT Raised to $63 at Truist Securities
$63.00
(was $56.73)
David MacDonald
·
Truist Financial
RadNet (RDNT) PT Raised to $55 at Truist Securities, 'conviction remains high in underlying business trends'
$55.00
(was $48.49)
David MacDonald
·
Truist Financial
United Airlines To Rally Around 37%? Here Are 10 Other Analyst Forecasts For Monday
$37.00
(was $33.02)
Quinn Bolton
·
Needham